Teladoc Health Reports Second Quarter 2025 Results

Go back to Teladoc Health Reports Second Quarter 2025 Results

Teladoc (TDOC) Tops Q2 EPS by 7c, Offers Guidance

July 29, 2025 4:10 PM EDT

Teladoc (NYSE: TDOC) reported Q2 EPS of ($0.19), may not compare to the analyst estimate of ($0.26). Revenue for the quarter came in at $631.9 million versus the consensus estimate of $622.54 million.

GUIDANCE:

Teladoc sees Q3 2025 EPS of ($0.20)-($0.35), versus the consensus of... More